活检确诊CIN1或正常宫颈女性的15年结局及相关辅因子的中国人群队列研究
该研究基于中国山西1999年入组的1997名35-45岁宫颈癌筛查女性队列,随访6、11、15年,评估活检确诊CIN1或正常宫颈的长期结局及相关辅因子。CIN1进展为CIN2+的15年累积率为24.0%,回归正常率为72.9%;正常宫颈15年进展率为5.2%。hrHPV阳性和细胞学异常程度与进展风险增加相关,较早性初潮与新发和重复HPV感染风险相关。
要点
- CIN1的15年进展为CIN2+累积率为24.0%,回归正常率为72.9%。
- 正常宫颈15年进展为CIN2+仅5.2%,超90%维持正常。
- hrHPV阳性和细胞学异常程度增加CIN2+进展风险。
核心结论
- CIN1或正常宫颈女性的临床随访策略可根据hrHPV和细胞学状态进行调整。
研究设计与样本
- 1999年在中国山西入组1997名35-45岁女性的宫颈癌筛查队列,随访6、11、15年,采用hrHPV DNA检测、液基细胞学和醋酸肉眼观察。
主要发现
- CIN1进展为CIN2+的6、11、15年累积率分别为7.5%、21.4%、24.0%,回归正常率分别为85.0%、76.7%、72.9%。
- 正常宫颈6、11、15年进展为CIN2+的累积率分别为0.7%、2.9%、5.2%,15年后超90%维持正常。
- hrHPV阳性的CIN1或正常宫颈进展为CIN2+的风险显著高于hrHPV阴性者。
- 细胞学异常程度加重与CIN2+进展风险增加相关。
- 较早性初潮者新发HPV感染和重复HPV感染风险更高。
临床怎么用
- 对CIN1或正常宫颈女性,可依据hrHPV和细胞学状态调整随访策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate long-term outcomes of biopsy-confirmed cervical intraepithelial neoplasia grade 1 (CIN1) or normal cervix and identify the cofactors during disease progression. METHODS: In 1999, a cervical cancer screening cohort in Shanxi, China, enrolled 1997 women aged 35-45. They were followed up at year 6, 11, and 15 after enrollment with high-risk human papillomavirus (hrHPV) DNA testing, liquid-based cytology, and visual inspection with acetic acid. Progression, persistence, and regression rates were calculated, stratified by baseline hrHPV and cytological status. Risk factors associated with hrHPV acquisition, persistence, and progression were examined. RESULTS: The cumulative rates of progression to CIN2+ among CIN1 over 6, 11, and 15 years were 7.5%, 21.4%, and 24.0%, respectively; the regression rates to normal cervix were 85.0%, 76.7%, and 72.9%, respectively. Over 6, 11, and 15 years, 0.7%, 2.9%, and 5.2% of normal cervix developed CIN2+, respectively, but over 90% remained normal after 15 years. CIN1 or normal cervix positive for hrHPV had significantly higher progression rates to CIN2+ than those without hrHPV. Similarly, the severity of cytological status was found to be associated with an increased risk of developing CIN2+. Women who had an earlier sexual debut were at a higher risk of acquiring new HPV infection and repeated HPV infections. CONCLUSIONS: Clinical follow-up strategies for women with CIN1 or normal cervix could be adjusted accordingly based on hrHPV/cytology status.
引用
- Hu SY, Rezhake R, Chen F, et al. Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China. Gynecol Oncol. 2020. PMID: 31937451. doi:10.1016/j.ygyno.2019.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。